BRVE — Braveheart Bio Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Braveheart Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2025 December 31st | |
|---|---|
| Period Length: | 12 M |
| Source: | PROSPECTUS |
| Standards: | USG |
| Status: | Final |
| Cash and Equivalents | |
| Cash and Short Term Investments | 89.2 |
| Prepaid Expenses | |
| Total Current Assets | 89.3 |
| Other Long Term Assets | |
| Total Assets | 89.3 |
| Accounts Payable | |
| Accrued Expenses | |
| Notes Payable / Short Term Debt | |
| Total Current Liabilities | 5.24 |
| Total Long Term Debt | |
| Total Debt | |
| Total Other Liabilities | |
| Total Liabilities | 5.33 |
| Redeemable Preferred Stock | |
| Common Stock | |
| Additional Paid In Capital | |
| Retained Earnings (Accumulated Deficit) | |
| Total Equity | 84 |
| Total Liabilities & Shareholders' Equity | 89.3 |
| Total Common Shares Outstanding |